Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360) | MicrobiomeTrials
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-01-15Est. Completion: 2027-11-22
Enrollment target: 300 participants
Locations
Arrhythmia Research Group, Jonesboro, Arkansas, United States
Scripps Memorial Hospital, La Jolla, California, United States
NCH Rooney Heart Institute, Naples, Florida, United States
Memorial Health University Medical Center, Savannah, Georgia, United States
Northwestern University, Chicago, Illinois, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Southcoast Health System, Fall River, Massachusetts, United States
Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
Mayo Clinic, Rochester, Minnesota, United States
The Valley Hospital, Paramus, New Jersey, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Northwell Health Lenox Hill Hospital, New York, New York, United States
Duke University Medical Center, Durham, North Carolina, United States
Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Bethesda North Hospital, Cincinnati, Ohio, United States
Other microbiome trials you might be interested in